Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in males with type 2 diabetes mellitus
NCT03052400Phase 2Terminated
- Sponsor
- Charles Drew University of Medicine & Science
- Start
- Feb 2017
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Mifepristone Arm with Placebo Arm (2 arms). Primary endpoint: Hemoglobin A1c at 3 months. Started Feb 2017; status: terminated.
02
Drugs
mifepristone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03052400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03052400.